| RS2069790642 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069791742 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069792041 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069792220 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069792273 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069792818 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2069793099 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069794139 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069795265 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069795315 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069795581 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069827755 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2069829602 |
ZEB1
|
Health Risk |
Likely pathogenic |
Corneal dystrophy, Fuchs endothelial |
| RS2069865899 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069867116 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069867387 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069867490 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2069867622 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069867738 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069868519 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069868919 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069869918 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069870034 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2069870374 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2069899081 |
COL4A3
|
Health Risk |
Likely pathogenic |
Benign familial hematuria, Benign familial hematuria |
| RS2069900248 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign familial hematuria, Autosomal dominant Alport syndrome |
| RS2069901772 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2069903710 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hematuria, benign familial |
| RS2069915167 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2069923072 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2069929443 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Alport syndrome 3b, autosomal recessive |
| RS2069936 |
PROC
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS2069936535 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2069945390 |
CHRNB1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 2C, Congenital myasthenic syndrome 2A |
| RS2069961546 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS2069962309 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2069980707 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2069981391 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2069982771 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS2069985189 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2069988351 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS2069991819 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS2069999514 |
TPK1
|
Health Risk |
Pathogenic |
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency, Childhood encephalopathy due to thiamine pyrophosphokinase deficiency |
| RS2070011218 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2070018439 |
FOXN1
|
Health Risk |
Pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS2070032216 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS2070033114 |
LPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipidemia, familial combined |
| RS2070033559 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2070034528 |
ATRX
|
Health Risk |
Pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2070035662 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Hematuria |
| RS2070037318 |
ATRX
|
Health Risk |
Pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2070047352 |
ATRX
|
Health Risk |
Pathogenic |
— |
| RS2070072539 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2070072794 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2070073417 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070073649 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070074 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity; other |
GALT POLYMORPHISM (DUARTE, D2) |
| RS2070074227 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2070074350 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070074822 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070075185 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070075234 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2070075481 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070076040 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070076088 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070076467 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070076529 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070076932 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070077052 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070077277 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070077334 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2070077385 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2070077732 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070078716 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070078996 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070079311 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070080 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS2070094 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2070102904 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070105179 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070107315 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070108683 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070108811 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070109067 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070109145 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070145822 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2070161874 |
PCK1
|
Health Risk |
Pathogenic |
Phosphoenolpyruvate carboxykinase deficiency, cytosolic |
| RS2070166483 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070167232 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070169785 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070170042 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070170274 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070170648 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070171459 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070171679 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070172428 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070172476 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070172706 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070173038 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2070197 |
IRF5
|
Health Risk |
risk factor |
SYSTEMIC LUPUS ERYTHEMATOSUS, ASSOCIATION WITH SUSCEPTIBILITY TO |